The organic anion transport system in the proximal tubule of the kidney is of major importance for the excretion of a variety of endogenous and potentially toxic exogenous substances. Furthermore, the clearance of model substrates (e.g. para-aminohippurate) of this system is used for the determination of renal blood flow. We investigated regulation of organic anion secretion in a way that allowed us to examine simultaneously regulation of overall transepithelial secretion and to estimate the separate contributions of regulation of the basolateral and apical transport steps to this overall regulation. The data were verified by measurement of initial basolateral uptake rate and initial apical efflux rate. Opossum kidney cells were used as a suitable model system for proximal tubule cells, and [
The organic anion transport system of the renal proximal tubule plays a crucial role in the excretion of a variety of potentially toxic compounds (1) . This system consists of a basolaterally located organic anion exchanger and a less well characterized transport step at the apical membrane (2) . The basolateral organic anion exchanger is a tertiary active transport system, dependent on an inward directed Na ϩ gradient to drive the uptake of ␣-ketoglutarate, which is then exchanged for organic anions (1) (2) (3) (4) . The basolateral exchanger for organic anions and dicarboxylates was cloned by three independent groups (5-7) in 1997, and called OAT1 (rat), ROAT1 (rat), or fROAT1 (winter flounder). Only recently, the homologous protein was cloned from human kidney and called hOAT1 or hPAHT (8, 9) . A number of mechanisms have been described for the apical efflux of organic anions (10) , which differ with species and experimental setup used. For example, a PAH 1 / dicarboxylate exchanger, a PAH/anion exchanger, and a membrane potential-dependent mechanism have been described (11) . Furthermore, there is evidence for the involvement of oatp, OAT-K1, and OAT-K2 (10, (12) (13) (14) (15) (16) . Thus, secretion of organic anions is mediated by a well described, tertiary active transport step at the basolateral membrane and a not yet settled, apical transport step.
Very little is yet known about the modulation of the secretory organic anion transport system. Nagai and co-workers (17) showed an inhibition of basolateral uptake and transepithelial secretion of organic anions in OK cells by parathyroid hormone via a staurosporine sensitive mechanism. Inhibition of basolateral organic anion transport during stimulation of protein kinase C (PKC) was reported in isolated tubules of kilifish (18) . The basolateral exchanger for organic anions and dicarboxylates in isolated proximal tubules of rabbit kidney was shown to be sensitive to inhibition of Ca 2ϩ /calmodulin-dependent protein kinase II, tyrosine kinase, phosphatidylinositol-3-kinase, and mitogen-activated protein kinases (MAPKs) (19) . Furthermore, inhibition of OAT1 by bradykinin and phenylephrine via PKC in isolated rabbit proximal tubules has been described (20) . In most of the studies, only regulatory events at the basolateral membrane were investigated. The study of Nagai and co-workers investigated transepithelial transport, but they used the rather unspecific kinase inhibitor staurosporine. Inhibition of net secretory transport (21) of organic anions by bradykinin and phenylephrine has been reported for isolated perfused rabbit proximal tubules. Recently, Henderson and co-workers (22) showed that PKC inhibits murine OAT without direct phosphorylation of the transport protein itself. Taken together, these studies give no detailed information concerning the contribution of the single transport steps to the regulation of transcellular secretion. To address this problem, we investigated transcellular secretion in combination with measurements of initial basolateral uptake rate and initial apical efflux rate.
In the present study, we determined the effect of epidermal growth factor (EGF) and MAPKs on PAH transport in OK cells. EGF and its receptor are known to be expressed in proximal tubular cells (23) . EGF has been suggested as a mediator of normal tubulogenesis and tubular regeneration after injury. A reduction of renal EGF expression and/or urinary excretion has been reported during acute and chronic tubular injury (24) . Additionally, EGF led to an increase in PAH excretion in rats (25) , indicating an influence of EGF on proximal tubular organic anion transport. MAPKs are known to be involved in renal stress response and represent an important downstream signal of the EGF pathway (26) .
Our data show that activation of PKC inhibits both the basolateral and the apical step of PAH secretion. Moreover, we show that MAPK activity is required for a proper activity of basolateral uptake step and the apical exit of PAH. EGF stimulates transepithelial secretion via stimulation of the basolateral uptake but does not affect the apical transport step. EGF leads to successive activation of the MAPKs, ERK kinase (MEK), and extracellular regulated kinase 1/2 (ERK1/2).
EXPERIMENTAL PROCEDURES

Cell Culture
OK cells were obtained from Dr. Biber (Department of Physiology, University of Zurich). Cells were maintained in culture at 37°C in a humidified 5% CO 2 , 95% air atmosphere. The growth medium was minimal essential medium, pH 7.4, supplemented with Earl's salts, nonessential amino acids, 10% (v/v) fetal calf serum (Biochrom KG, 12213 Berlin, FRG), and 26 mmol/liter NaHCO 3 . Cells were cultured on permeable supports (3-m pore diameter; Falcon, Becton Dickinson Labware, Franklin Lakes, NJ) for transport measurements. The effective growth area on one permeable support was 4.3 cm 2 /filter. All studies were performed between passages 60 and 100. The seeding density was 0.4⅐10 6 cm
Ϫ2
. The medium was changed every third day, and the monolayers were used for experiments at day 10 after seeding. The effect of 10 Ϫ7 M phorbol 12-myristate 13-acetate or 5 ϫ 10 Ϫ5 M DOG on PAH secretion was determined in nonquiescent and quiescent cells, as shown in Fig. 1 . OK cells were made quiescent by cultivating them in serum depleted cell culture medium for 24 h before the experiments. In both cases, secretion (Fig. 1A ) was reduced to a greater extent than cellular content (Fig. 1B) , indicating that apical transport may be affected by PKC. Moreover, the effects were more pronounced in quiescent (means serum depleted for 24 h) cells (Fig. 1, right panel) as compared with nonquiescent cells (Fig. 1, left panel) . In nonquiescent cells EGF showed no effect on cellular PAH content or transepithelial PAH secretion (data not shown). Because fetal calf serum contains a variety of chemokines, it is evident that investigation of the effect of an isolated chemokine is only possible in the absence of serum. As shown for PKC and mentioned for EGF, the effects on organic anion transport in OK cells were more pronounced or only apparent when cells were made quiescent. Thus, quiescent OK cells were used for all subsequent experiments.
Transport Measurements
The volumes of the apical and basolateral compartment were 1.3 and 2.5 ml to avoid hydrostatic pressure differences. Before each experiment, the cells were washed three times with phosphate-buffered Ringer (138 mmol/liter NaCl, 1 mmol/liter NaH 2 
Western Blot Analysis
OK cells were rinsed three times with PBS followed by a 10-min incubation with EGF and/or PD98059. Subsequently cells were washed with ice-cold PBS three times and lysed in ice-cold Triton X-100 lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 50 mM NaF, 5 mM EDTA, 40 mM ␤-glycerophosphate, 200 M sodium orthovanadate, 0.1 mM phenylmethylsulfonyl fluoride, 1 g/ml leupeptin, 1 M pepstatin A, 1% Triton X-100) for 25 min at 4°C. Insoluble material was removed by centrifugation at 12,000 ϫ g for 15 min at 4°C. The protein content was determined using a microbicinchoninic acid assay (Pierce) with bovine serum albumin as a standard. Cell lysates were matched for protein, separated by 12% SDS-polyacrylamide gel electrophoresis, and transferred to a polyvinylidene difluoride microporous membrane. Subsequently, membranes were blotted with rabbit anti-pERK1/2 (p42/p44) antibody (New England Biolabs). The primary antibody was detected using alkaline phosphatase-conjugated goat anti rabbit IgG visualized by ECL Western blotting reagents and Hyperfilm ECL (Amersham Pharmacia Biotech). According to the manufacturer's handbook Hyper- film ECL exhibits a linear response to the light produced from enhanced chemiluminescence. Additionally, linearity was verified for our experimental conditions by a dilution series with increasing amounts of total cell protein. Western blotting was performed with protein from five independent extractions from five independent cell culture passages. Blots were analyzed using SigmaGel 2000 Software (Jandel Scientific).
Processing of Experimental Data
10-min transport-According to our measurements ( Fig. 2A) secretory transport of organic anions in the OK clone used is detectable after 3-4 min and is then linear for at least 1 h (data not shown). Thus, secretory transport after 10 min represents the linear phase of secretion. Therefore, the amount of radiolabeled PAH in the apical compartment after 10 min was used to measure PAH secretion. The quantity of PAH in the cells is denominated cellular content. Summing up the values for PAH secretion and for cellular PAH content gives the basolateral uptake of PAH, i.e. the total amount of PAH transported across the basolateral membrane during 10 min. Additionally, we calculated the ratio of secretion to cellular content of PAH (the secretion-to-content ratio). Introducing these parameters enabled us to gain information regarding the contribution of basolateral and/or the apical transport step(s) to the overall secretion of PAH.
Basolateral Uptake during the First Minute-Under our experimental conditions uptake of PAH is linear at least during the first 1.5 min as shown in Fig. 2B (right panel), and no net secretion of PAH occurs (data not shown). Thus, the cellular PAH content after 1 min represents the initial basolateral uptake rate. Thus, the predictions concerning the basolateral part of PAH transport derived from the 10-min transport experiments were verified by the 1-min data.
Apical Efflux of PAH during the First Minute-After preloading the cells as described above, we determined the apical efflux of [ Because the volume of the apical compartment is about 1000 times that of the cells, there is a large outward gradient during the entire experimental period. According to Fig. 2C (right panel) , efflux into the apical compartment is linear at least during 1.5 min, and, thus, the gradient is not collapsed in the time frame investigated. Therefore, the apical efflux during 1 min represents the initial apical efflux rate.
Data Analysis
Data are presented as the means Ϯ S.E. n is given in the text or in the figures. n represents the number of culture plates or filters used. cultured on permeable supports, a well characterized model system to investigate organic anion secretion (27) (28) (29) . Probenecid (10 mM), the classical inhibitor of organic anion transport, and a 1000-fold excess of unlabeled PAH, both inhibited uptake and secretion of [ 14 C]PAH by more than 95% (data not shown). Thus, our particular cell clone transports organic anions in accordance to the published data mentioned in the introduction.
PKC Affects Basolateral and Apical Transport-Stimulation of PKC by 5 ϫ 10
Ϫ5 M DOG reduced secretion of PAH (Fig. 3A) , whereas the cellular content (Fig. 3B) was not significantly different from control. Adding up secretion and cellular content of PAH gives the amount of PAH transported across the basolateral membrane (Fig. 3C) . Transport across the basolateral membrane was reduced by DOG, in agreement with other studies (18 -20) . Furthermore, the decreased secretion-to-content ratio (Fig. 3D) indicates that the apical transport step is also inhibited by PKC. However, there is another possible explanation. The apical transport is carrier mediated and thus has a hyperbolic relationship to substrate concentration. A decrease in intracellular concentration could reduce this ratio, without inhibition of the apical step itself. Thus, experiments on initial transport rates will have to decide what kind of explanation applies to these data.
Simultaneous inhibition of apical and basolateral transport was confirmed by measurement of initial apical efflux rate and initial basolateral uptake rate. As shown in Fig. 4A , activation of PKC reduced the initial apical efflux rate, thereby leading to a decreased relative amount of PAH in the apical bath as compared with control. In addition, Fig. 4B shows that stimulation of PKC reduced the initial basolateral uptake rate of PAH. By contrast, inhibition of PKC with 10 Ϫ7 M BIM increased basolateral uptake of PAH (data not shown). Thus, the basolateral organic anion transport in OK cells is regulated by PKC in agreement with data published previously (19, 20) .
EGF Stimulates Transepithelial Secretion-EGF increased cellular content (Fig. 5B ) and transepithelial secretion (Fig. 5A ) of PAH. However, EGF did not affect secretion-to-content ratio for PAH (Fig. 5D ) at all, indicating that EGF stimulates basolateral PAH transport in OK cells but does not affect the apical transport step. Initial efflux experiments showed no change in PAH efflux across the apical membrane in EGF treated cells (Fig. 6A) . These data confirm the predictions derived from the 10-min transport experiments with EGF (Fig. 5) . As shown in Fig. 6B , EGF stimulates the initial basolateral uptake rate of PAH in agreement with the prediction derived from the 10-min experiments.
MAPKs Affect Basolateral and Apical Transport-It is known that EGF uses the MAPK pathway also in OK cells (30) . Therefore, we investigated the effect of substances that inhibit MAPK activation. Transepithelial secretion (Fig. 7A ) and basolateral uptake (Fig. 7C ) of PAH were reduced by PD98059 (inhibitor of MEK), whereas cellular PAH content (Fig. 7B) was increased 3-fold as compared with control. The secretion-tocontent ratio (Fig. 7D) was dramatically decreased in the pres- ence of PD98059. These data indicate a strong inhibitory effect of PD98059 on the apical transport step of PAH secretion. Furthermore, it is possible that the increased cellular content of PAH results solely from the strong inhibition of the apical exit step of PAH, whereas the basolateral transport step remains unchanged. This is also true for the observed reduction of basolateral uptake in Fig. 7 . In fact, even an increase in basolateral transport activity would be in agreement with these data. Thus, in this particular configuration, it is impossible to draw a final conclusion concerning the basolateral transport step. As Fig. 8A clearly shows, the prediction concerning the apical step is confirmed by the data obtained from efflux experiments. PD98059 inhibited initial apical efflux rate significantly. Initial basolateral uptake rate of PAH (Fig. 8B) is also reduced by PD98059. These data show that basolateral uptake of PAH in OK cells is inhibited by inhibition of MEK. Increasing the concentration of PD98059 to 50 M (Fig. 8B) , which represents the maximal effective concentration, leads to an increased inhibition of initial basolateral uptake rate of PAH, indicating a dose-dependent action of PD98059 on the basolateral transport.
In summary, transepithelial secretion of PAH in OK cells is under the stimulatory control of the mitogen-activated protein kinase kinase MEK. Increased secretion when MEK is active results from a stimulation of both basolateral and apical transport (Fig. 9A) . Similar results were obtained with another, structurally different, MEK inhibitor U0126 (data not shown).
EGF Acts on Basolateral Uptake via Successive Activation of MEK and ERK-As already mentioned, it is known that the MAPK pathway is stimulated by EGF in OK cells (30) . Thus, we investigated whether the stimulatory effect of EGF on basolateral PAH transport is mediated by MAPK. As shown in Fig. 10 , inhibition of the MAPK MEK by PD98059 or U0126 completely abolishes the stimulatory effect of EGF on initial basolateral PAH uptake. These data indicate that the stimulatory effect of EGF on basolateral uptake is mediated by the activation of MEK.
As shown in Fig. 11 , EGF leads to increased phosphorylation of ERK1/2 in OK cells within 10 min. PD98059 alone, slightly but significantly, decreased the amount of pERK1/2 as compared with controls. These data are in good agreement with the effects on PAH transport. However, EGF increased phosphorylation of ERK1/2 is reduced by inhibition of MEK with PD98059, whereas EGF-stimulated uptake of PAH is totally abolished by PD98059. We explain this apparent discrepancy with the existence of intermediate signaling steps between ERK and basolateral organic anion transport, as discussed in detail later on.
Finally we tested whether preincubation for 10 min with EGF or PD98059 affects glutarate uptake in OK cells. Glutarate is a nonmetabolizable analogue of the dicarboxylate ␣-ketoglutarate. EGF and PD98059 did not affect basolateral uptake of glutarate (control: 1.2 Ϯ 0.1, n ϭ 3; 10 ng/ml EGF: 1.4 Ϯ 0.1, n ϭ 3; 5 M PD98059: 1.3 Ϯ 0.3, n ϭ 6; in pmol⅐cm Ϫ2 ⅐10 min Ϫ1 ). Furthermore, EGF did not affect apical glutarate uptake (control: 0.9 Ϯ 0.1, n ϭ 3; 10 ng/ml EGF: 1.1 Ϯ 0.1, n ϭ 3; Ϫ6 M during 1 min was determined as described. The cells were incubated with EGF 10 min before the uptake was determined. In between, the cell epithelia were washed once with PBS. n ϭ 6 for every bar. *, p Ͻ 0.05 versus control.
in pmol⅐cm Ϫ2 ⅐10 min Ϫ1 ). Thus, availability of intracellular counterions for PAH uptake is not altered by EGF or PD98059. Previously published data showed no effect of PD98059 on basolateral glutarate uptake (19) . Taken together, these data present strong evidence that EGF stimulates exchange of dicarboxylates and organic anions via stimulation of the ERK1/2 (Fig. 9C) .
DISCUSSION
The Experimental Setup-The purpose of the present study was (a) to gain more information concerning the overall regulation of the proximal tubule organic anion transport and (b) to investigate the contribution of the basolateral and apical transport steps to this regulation. As shown for EGF, we were able to determine their effects on the basolateral and apical transport steps simultaneously with their effects on transepithelial secretion. However, inhibition of MEK by PD98059 led to a configuration (reduced secretion, increased content, reduced uptake, and reduced secretion-to-content ratio) where determination of the contribution of the basolateral transport step simultaneously with secretion was not possible, indicating the limitations of the method. This is also true for the DOG effect presented. However, with the help of initial apical efflux experiments and determination of the initial basolateral transport rate it is possible to investigate apical and basolateral transport steps separately. Nevertheless, we show that it is possible to estimate the site of action of a chemokine on the secretory transport simultaneously with transepithelial transport, although transport occurs across two membranes (and the cytosol). Thus, the particular processing of the 10-min transport data presented here is suitable to obtain a first estimate regarding the site of action of a given modulator of secretory transport.
Stimulation of PKC inhibits basolateral uptake rate and inhibition of MEK decreases basolateral uptake rate of PAH (Fig. 9A) . These data are in agreement with the action of PKC (18 -20) and MAPK (19) in isolated proximal tubules and again show the suitability of the OK cell system used. Additionally, we show for the first time that PKC inhibits and MEK stimulates the apical step of organic anion secretory transport in a proximal tubule derived cell line (Fig. 9A) . Because the specific PKC inhibitors calphostin C and bisindolylmaleimide stimulate basolateral uptake of PAH, the observed inhibitory action of DOG is due to an interaction with regulatory cascades and not due to nonspecific or even toxic action. Furthermore, the calphostin C-induced stimulation of PAH uptake was prevented by both phorbol 12-myristate 13-acetate and DOG (data not shown). Systematic changes in mannitol flux were not observed with any of the substances used. Thus, no changes in epithelial tightness were induced, and the measured changes in PAH transport are not due to altered paracellular flux. The unchanged epithelial tightness, together with the short exposure time (10 min) and the moderate concentrations used, make it highly unlikely that any observed effect is due to Ϫ6 M during 1 min was determined as described. The cells were incubated with PD98059 (5 ϫ 10 Ϫ6 M or 5 ϫ 10 Ϫ5 M) for 10 min before the uptake was determined. Between this incubation and the uptake measurement, the cell epithelia were washed once with PBS. n for every bar is given in parentheses. *, p Ͻ 0.05 versus control. unspecific toxic actions.
EGF Stimulates Organic Anion Secretion-As the above mentioned maneuvers act directly on intracellular signaling pathways, we investigated the effect of more physiologically or pathophysiologically relevant stimuli, namely EGF. We show for the first time that EGF increases the secretion of PAH in OK cells by a stimulation of the basolateral uptake step. EGF does not affect the apical transport step (Fig. 9B) .
The effect of EGF on basolateral uptake is mediated by MEK, because two specific, structurally distinct inhibitors of MEK (PD98059 and U0126) completely abolished EGF induced stimulation of initial basolateral PAH uptake. As shown in Fig. 8B , 5 M PD98059 led to a slight decrease of initial PAH uptake. This is in parallel with the decrease of ERK1/2 phosphorylation induced by 5 M PD98059. However, the same concentration of PD98059 completely prevented the EGF-induced stimulation of initial basolateral PAH uptake. This was also the case for the structurally distinct MEK inhibitor U0126. The fact that inhibition of MEK decreased uptake only slightly but abolished EGF-stimulated uptake completely is strong evidence for the fact that EGF acts on basolateral transport via stimulation of MEK. Moreover, as already mentioned above, no secretion of organic anions in OK cells was detected during the first min. Thus, alterations of the apical transport step should not influence initial basolateral uptake rate.
Inhibition of MEK prevented EGF-induced stimulation of basolateral PAH uptake completely; however, it reduced EGF ]PAH that is stimulated by EGF is given by the difference in uptake after EGF and untreated controls, the difference in uptake after EGF in presence of PD98059 and PD98059 alone, and the difference in uptake after EGF in presence of U0126 and U0126 alone. Epithelia were washed once with PBS between incubation and uptake measurement. n ϭ 9 for every bar. *, p Ͻ 0.05 versus 0. induced ERK1/2 activation only partially. We consider this difference of action as evidence that ERK1/2 does not act directly on basolateral organic anion uptake but via one or more intermediate signaling steps. In fact, preliminary data from our laboratory indicate that phospholipase A 2 is involved in downstream signaling following ERK1/2 activation (31). These intermediate steps (as e.g. phospholipase A 2 ) possibly modulate the signal downstream of ERK1/2 in such a way that a partial inhibition of ERK1/2 activation leads to a complete inhibition of PAH uptake stimulation. This could be explained by a certain ERK1/2 activation threshold that has to be exceeded to stimulate the downstream signals. Thus, we hypothesize that EGF stimulates basolateral organic anion uptake via the successive activation of MEK, ERK, and additional downstream signaling steps (Fig. 9C) . However, additional experiments will be necessary to clarify the downstream signal transduction and amplification network with respect to organic anion uptake in more detail.
As seen in the control lane of Fig. 11B , OK cells show a certain intrinsic ERK1/2 activation, although they were serum depleted for 24 h. Our observations indicate that OK cells with higher intrinsic ERK1/2 activation show higher control levels of basolateral PAH uptake as compared with those with a lower ERK1/2 activation (data not shown). These data again support the hypothesis that ERK1/2 activity regulates organic anion transport in OK cells.
Because the effects of EGF were studied after 10 min of exposure, it can be excluded that the regulatory events observed resulted from changes in protein synthesis. However, up to now we can only speculate on the molecular events involved in the observed regulatory phenomena. Possible mechanisms include an increased insertion of preformed transport protein by fusion of vesicles with the basolateral membrane in response to EGF. Of course EGF could also lead to stimulation of transport proteins in the cell membrane, by e.g. phosphorylation. Future experiments will investigate the effects of EGF on the affinity (K m ) and the maximum transport rate (V max ) of basolateral organic anion uptake in more detail.
By contrast to the events at the basolateral membrane, stimulation of MEK by EGF did not lead to a stimulation of the apical transport step, although PD98059 data indicate a regulatory role of MEK on the apical transport step, too. This apparent discrepancy could be explained by the fact that basal MEK activity already induces maximal stimulation of apical transport. Consequently, reduction of basal ERK1/2 activity by PD98059 (Fig. 11 ) leads to reduced apical and basolateral transport, whereas activation of MEK by EGF affects only the basolateral step. Another possible explanation is the involvement of additional signal pathways downstream of EGF, which might antagonize the MEK effect on apical transport but not on basolateral transport. Finally, there is the possibility of basolateral signaling microdomains, which confine the effect of EGF. Future experiments will have to explain this apparent discrepancy.
PAH clearance is routinely used for the determination of renal blood flow, based on the assumption of a high and constant renal PAH extraction. Because PAH extraction would vary according to the regulatory state of its transport system, it is conceivable that the determination of renal blood flow from PAH clearance may lead to under-or overestimation. Corrigan et al. (32) , for example, described a decreased renal PAH extraction after postischemic acute renal failure in humans, leading to severe underestimation of renal blood flow. After renal injury, a rapid fall of EGF mRNA in the kidney was measured (26) . We could show that the basolateral step of PAH secretory transport is under stimulatory control of EGF, which is in agreement with excretion data from rat (25) and could explain, at least in part, the above mentioned data from Corrigan.
In summary, we were able to determine the site of regulation of the secretory transport of organic anions. The results obtained were confirmed by measurements of initial basolateral uptake rate and initial apical efflux rate. Thus, we could show that activation of PKC inhibits not only the basolateral but also the apical step of organic anion secretion. We also showed that MEK stimulates not only the basolateral but also the apical transport step of organic anion secretion. Additionally, we presented data indicating a stimulation of the organic anion secretion by EGF. This stimulation resulted from an increase of the basolateral uptake rate only. Furthermore, we showed that EGF stimulates the basolateral uptake of organic anions via successive activation of MEK and ERK. In conclusion, the excretion of organic anions in proximal tubular cells seems to be a regulated and therefore variable process. This may be particularly important under pathophysiological conditions.
